UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Neutralizing Antibody Response during Acute and Chronic Hepatitis C Virus Infection

Proceedings of the National Academy of Sciences - PNAS, 2004-07, Vol.101 (27), p.10149-10154

2004

Volltextzugriff (PDF)

Differential selenium uptake by periphyton in boreal lake ecosystems

Environmental pollution (1987), 2022-07, Vol.305, p.119304-119304, Article 119304

2022

Volltextzugriff (PDF)

Development of Real-Time PCR Assays for Rapid Detection of Pfiesteria piscicida and Related Dinoflagellates

Applied and Environmental Microbiology, 2000-11, Vol.66 (11), p.4641-4648

2000

Volltextzugriff (PDF)

Solithromycin treatment for 13 weeks improves histological parameters in nonalcoholic steatohepatitis: results of an ongoing pilot study

Journal of hepatology, 2017, Vol.66 (1), p.S586-S586

2017

Volltextzugriff (PDF)

1211 EMERGENCE AND PERSISTENCE OF NS5B MUTATIONS FOLLOWING COMBINATION TREATMENT WITH TEGOBUVIR (GS-9190) PLUS STANDARD OF CARE-LONG-TERM FOLLOW-UP FROM THE PHASE IIB STUDY GS-US-196-0103

Journal of hepatology, 2011-03, Vol.54, p.S478-S479

2011

Volltextzugriff (PDF)

76 TENOFOVIR DISOPROXIL FUMARATE (TDF) VERSUS EMTRICITABINE PLUS TDF FOR TREATMENT OF CHRONIC HEPATITIS B (CHB) IN SUBJECTS WITH PERSISTENT VIRAL REPLICATION RECEIVING ADEFOVIR DIPIVOXIL (ADV)

Journal of hepatology, 2008, Vol.48, p.S34-S34

2008

Volltextzugriff (PDF)

1225 CHARACTERIZATION OF VIRAL RESISTANCE MUTATIONS IN GENOTYPE 1 HCV PATIENTS RECEIVING COMBINATION THERAPY WITH A PROTEASE INHIBITOR AND A POLYMERASE INHIBITOR WITH OR WITHOUT RIBAVIRIN

Journal of hepatology, 2011-03, Vol.54, p.S484-S484

2011

Volltextzugriff (PDF)

126 A PHASE-2B TRIAL TO EVALUATE THE SAFETY, TOLERABILITY AND EFFICACY OF A CASPASE INHIBITOR GS-9450, IN ADULTS FAILING PEG/RBV THERAPY FOR CHRONIC HCV INFECTION

Journal of hepatology, 2011-03, Vol.54, p.S55-S56

2011

Volltextzugriff (PDF)

Antibiotic Usage and the Development of Resistance

Clinical infectious diseases, 2015-04, Vol.60 (7), p.1139-1140

2015

Volltextzugriff (PDF)

445 A PHASE 2B TRIAL COMPARING 24 TO 48 WEEKS TREATMENT WITH TEGOBUVIR (GS-9190)/PEG/RBV TO 48 WEEKS TREATMENT WITH PEG/RBV FOR CHRONIC GENOTYPE 1 HCV INFECTION

Journal of hepatology, 2011-03, Vol.54, p.S181-S181

2011

Volltextzugriff (PDF)

Determinants of viral clearance and persistence during acute hepatitis C virus infection

The Journal of experimental medicine, 2001-11, Vol.194 (10), p.1395-1406

2001

Volltextzugriff (PDF)

425 FOUR-WEEK TREATMENT WITH GS-9256 AND TEGOBUVIR (GS-9190), ± RBV ± PEG, RESULTS IN ENHANCED VIRAL SUPPRESSION ON FOLLOW-UP PEG/RBV THERAPY, IN GENOTYPI 1A/1B HCV PATIENTS

Journal of hepatology, 2011-03, Vol.54, p.S172-S172

2011

Volltextzugriff (PDF)

“Real-time” polymerase chain reaction

Gastroenterology (New York, N.Y. 1943), 1999-03, Vol.116 (3), p.763-765

Oldach, David

1999

Volltextzugriff (PDF)

273 SHORT TERM SAFETY, TOLERABILITY, PHARMACOKINETICS AND PRELIMINARY ACTIVITY OF GS-9450, A SELECTIVE CASPASE INHIBITOR, IN PATIENTS WITH CHRONIC HCV INFECTION

Journal of hepatology, 2010, Vol.52, p.S114-S115

2010

Volltextzugriff (PDF)

Heteroduplex Mobility Assay-Guided Sequence Discovery: Elucidation of the Small Subunit (18S) rDNA Sequences of Pfiesteria piscicida and Related Dinoflagellates from Complex Algal Culture and Environmental Sample DNA Pools

Proceedings of the National Academy of Sciences - PNAS, 2000-04, Vol.97 (8), p.4303-4308

2000

Volltextzugriff (PDF)

Solithromycin, a novel macrolide, does not prolong cardiac repolarization: a randomized, three-way crossover study in healthy subjects

Journal of antimicrobial chemotherapy, 2017-02, Vol.72 (2), p.515-521

2017

Volltextzugriff (PDF)

Genetic polymorphism in Gymnodinium galatheanum chloroplast DNA sequences and development of a molecular detection assay

Molecular ecology, 2001-02, Vol.10 (2), p.515-523

2001

Volltextzugriff (PDF)

2008 DOSE-RANGING, THREE-DAY MONOTHERAPY STUDY OF THE HCV NS3 PROTEASE INHIBITOR GS-9256

Journal of hepatology, 2010, Vol.52, p.S466-S467

2010

Volltextzugriff (PDF)

GB virus-C (hepatitis G virus) nostalgia

Kidney international, 1998-06, Vol.53 (6), p.1809-1809

Oldach, D

1998

Volltextzugriff (PDF)

903 TENOFOVIR DISOPROXIL FUMARATE (TDF) VERSUS EMTRICITABINE PLUS TDF (FTC/TDF) FOR TREATMENT OF CHRONIC HEPATITIS B (CHB) IN PATIENTS WITH PERSISTENT VIRAL REPLICATION RECEIVING ADEFOVIR DIPIVOXIL

Journal of hepatology, 2009, Vol.50, p.S328-S328

2009

Volltextzugriff (PDF)

Use of renal allografts from donors positive for hepatitis B core antibody confers minimal risk for subsequent development of clinical hepatitis B virus disease

Transplantation, 1997-12, Vol.64 (12), p.1781

1997

Volltextzugriff (PDF)

SAT-299 - Solithromycin treatment for 13 weeks improves histological parameters in nonalcoholic steatohepatitis: results of an ongoing pilot study

Journal of hepatology, 2017, Vol.66 (1), p.S586-S586

2017

Volltextzugriff (PDF)

Highly Divergent SSU rRNA Genes Found in the Marine Ciliates Myrionecta rubra and Mesodinium pulex

Protist, 2004-09, Vol.155 (3), p.347-359

2004

Volltextzugriff (PDF)

Associations between fish health and Pfiesteria spp. in Chesapeake Bay and mid-Atlantic estuaries

Harmful algae, 2006-09, Vol.5 (4), p.352-362

2006

Volltextzugriff (PDF)

A Mysterious Death

The New England journal of medicine, 1998-06, Vol.338 (24), p.1764-1769

1998

Volltextzugriff (PDF)

1 – 25 von 132

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(120)
Mit Volltextzugriff
(108)

Publikationsform

Artikel
(128)
Tagungsberichte
(4)

Sprache

Englisch
(131)
Deutsch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Neutralizing Antibody Response during Acute and Chronic Hepatitis C Virus Infection

Differential selenium uptake by periphyton in boreal lake ecosystems

Development of Real-Time PCR Assays for Rapid Detection of Pfiesteria piscicida and Related Dinoflagellates

Solithromycin treatment for 13 weeks improves histological parameters in nonalcoholic steatohepatitis: results of an ongoing pilot study

1211 EMERGENCE AND PERSISTENCE OF NS5B MUTATIONS FOLLOWING COMBINATION TREATMENT WITH TEGOBUVIR (GS-9190) PLUS STANDARD OF CARE-LONG-TERM FOLLOW-UP FROM THE PHASE IIB STUDY GS-US-196-0103

76 TENOFOVIR DISOPROXIL FUMARATE (TDF) VERSUS EMTRICITABINE PLUS TDF FOR TREATMENT OF CHRONIC HEPATITIS B (CHB) IN SUBJECTS WITH PERSISTENT VIRAL REPLICATION RECEIVING ADEFOVIR DIPIVOXIL (ADV)

1225 CHARACTERIZATION OF VIRAL RESISTANCE MUTATIONS IN GENOTYPE 1 HCV PATIENTS RECEIVING COMBINATION THERAPY WITH A PROTEASE INHIBITOR AND A POLYMERASE INHIBITOR WITH OR WITHOUT RIBAVIRIN

126 A PHASE-2B TRIAL TO EVALUATE THE SAFETY, TOLERABILITY AND EFFICACY OF A CASPASE INHIBITOR GS-9450, IN ADULTS FAILING PEG/RBV THERAPY FOR CHRONIC HCV INFECTION

Antibiotic Usage and the Development of Resistance

445 A PHASE 2B TRIAL COMPARING 24 TO 48 WEEKS TREATMENT WITH TEGOBUVIR (GS-9190)/PEG/RBV TO 48 WEEKS TREATMENT WITH PEG/RBV FOR CHRONIC GENOTYPE 1 HCV INFECTION

Determinants of viral clearance and persistence during acute hepatitis C virus infection

425 FOUR-WEEK TREATMENT WITH GS-9256 AND TEGOBUVIR (GS-9190), ± RBV ± PEG, RESULTS IN ENHANCED VIRAL SUPPRESSION ON FOLLOW-UP PEG/RBV THERAPY, IN GENOTYPI 1A/1B HCV PATIENTS

“Real-time” polymerase chain reaction

273 SHORT TERM SAFETY, TOLERABILITY, PHARMACOKINETICS AND PRELIMINARY ACTIVITY OF GS-9450, A SELECTIVE CASPASE INHIBITOR, IN PATIENTS WITH CHRONIC HCV INFECTION

Heteroduplex Mobility Assay-Guided Sequence Discovery: Elucidation of the Small Subunit (18S) rDNA Sequences of Pfiesteria piscicida and Related Dinoflagellates from Complex Algal Culture and Environmental Sample DNA Pools

Solithromycin, a novel macrolide, does not prolong cardiac repolarization: a randomized, three-way crossover study in healthy subjects

Genetic polymorphism in Gymnodinium galatheanum chloroplast DNA sequences and development of a molecular detection assay

2008 DOSE-RANGING, THREE-DAY MONOTHERAPY STUDY OF THE HCV NS3 PROTEASE INHIBITOR GS-9256

GB virus-C (hepatitis G virus) nostalgia

903 TENOFOVIR DISOPROXIL FUMARATE (TDF) VERSUS EMTRICITABINE PLUS TDF (FTC/TDF) FOR TREATMENT OF CHRONIC HEPATITIS B (CHB) IN PATIENTS WITH PERSISTENT VIRAL REPLICATION RECEIVING ADEFOVIR DIPIVOXIL

Use of renal allografts from donors positive for hepatitis B core antibody confers minimal risk for subsequent development of clinical hepatitis B virus disease

SAT-299 - Solithromycin treatment for 13 weeks improves histological parameters in nonalcoholic steatohepatitis: results of an ongoing pilot study

Highly Divergent SSU rRNA Genes Found in the Marine Ciliates Myrionecta rubra and Mesodinium pulex

Associations between fish health and Pfiesteria spp. in Chesapeake Bay and mid-Atlantic estuaries

A Mysterious Death

Suchergebnisse filtern